Suchergebnisse - "Tabernero, J"

PubPharm (17)

1

Antitumor activity of lurbinectedin in combination with oral capecitabine in patients with metastatic breast cancer

enthalten in: ESMO open | 2022

von Awada, A. | Boni, V. | Moreno, V. | +7

2

Two phase I studies of BI 836880, a vascular endothelial growth factor/angiopoietin-2 inhibitor, administered once every 3 weeks or once weekly in patients with advanced solid tumors

enthalten in: ESMO open | 2022

von Le Tourneau, C. | Becker, H. | Claus, R. | +10

3

Phase I, first-in-human study of MSC-1 (AZD0171), a humanized anti-leukemia inhibitory factor monoclonal antibody, for advanced solid tumors

enthalten in: ESMO open | 2022

von Borazanci, E. | Schram, A. | Garralda, E. | +20

4

Safety, pharmacokinetics, and antitumor activity of the anti-CEACAM5-DM4 antibody-drug conjugate tusamitamab ravtansine (SAR408701) in patients with advanced solid tumors : first-in-human dose-escalation study

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2022

von Gazzah, A. | Bedard, P. | Hierro, C. | +9

5

Trifluridine/tipiracil in combination with oxaliplatin and either bevacizumab or nivolumab in metastatic colorectal cancer : a dose-expansion, phase I study

enthalten in: ESMO open | 2021

von Bordonaro, R. | Calvo, A. | Auriemma, A. | +16

6

Antitumor activity of ipatasertib combined with chemotherapy : results from a phase Ib study in solid tumors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2020

von Isakoff, S. | Tabernero, J. | Molife, L. | +18

7

Phase I study of FOLFIRI plus pimasertib as second-line treatment for KRAS-mutated metastatic colorectal cancer

enthalten in: British journal of cancer | 2015

von Macarulla, T. | Cervantes, A. | Tabernero, J. | +10

8

Abituzumab combined with cetuximab plus irinotecan versus cetuximab plus irinotecan alone for patients with KRAS wild-type metastatic colorectal cancer : the randomised phase I/II POSEIDON trial

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2015

von Élez, E. | Kocáková, I. | Höhler, T. | +14

9

Phase I/IIa study evaluating the safety, efficacy, pharmacokinetics, and pharmacodynamics of lucitanib in advanced solid tumors

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von Soria, J. | DeBraud, F. | Bahleda, R. | +15

ErratumIn: Ann Oncol. 2015 Feb;26(2):445 Dientsmann, R [corrected to Dienstmann, R]

10

Capturing intra-tumor genetic heterogeneity by de novo mutation profiling of circulating cell-free tumor DNA : a proof-of-principle

enthalten in: Annals of oncology : official journal of the European Society for Medical Oncology | 2014

von De Mattos-Arruda, L. | Weigelt, B. | Cortes, J. | +16

ErratumIn: Ann Oncol. 2018 Nov 1;29(11):2268. - PMID 29718117